What is the generic name of Edarbi?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Generic Name of Edarbi

The generic name of Edarbi is azilsartan medoxomil 1.

Key Details

Azilsartan medoxomil is a prodrug that is rapidly hydrolyzed to its active form, azilsartan, in the gastrointestinal tract during absorption 1. The drug substance used in Edarbi tablets is actually the potassium salt form, known by the US accepted name azilsartan kamedoxomil 1.

Chemical Composition

  • Edarbi 40 mg tablets contain 42.68 mg of azilsartan kamedoxomil (equivalent to 40 mg azilsartan medoxomil)
  • Edarbi 80 mg tablets contain 85.36 mg of azilsartan kamedoxomil (equivalent to 80 mg azilsartan medoxomil) 1

Drug Class

Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) used to treat hypertension in adults 1, 2, 3. It was the eighth ARB approved by the FDA for this indication 3.

The active metabolite azilsartan works by selectively blocking the binding of angiotensin II to the AT₁ receptor, thereby antagonizing vasoconstriction and aldosterone secretion 1, 2.

References

Research

Azilsartan medoxomil: a review of its use in hypertension.

Clinical drug investigation, 2012

Research

Azilsartan medoxomil (Edarbi) the eighth ARB.

The Medical letter on drugs and therapeutics, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.